MAO inhibitors for treatment-resistant depression: Bringing an updated perspective on pioneering drugs

In the 1950s, monoamine oxidase inhibitors transformed the pharmacological treatment of mental disorders as the first class of antidepressant drugs. Currently considered third-line medications for treatment-resistant depression, they are markedly underutilized. Despite the benefits of these drugs, c...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Larissa Junkes, Laiana A. Quagliato, Jose C. Appolinario, Richard I. Shader, Antonio E. Nardi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-09-01
Serie:	Pharmacological Research
Soggetti:	Monoamine Oxidase Inhibitors Antidepressive Agents Pharmacology Serotonin Syndrome, Hypertensive Crisis Tranylcypromine Psychopharmacology
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1043661825003019
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!